RIGEL PHARMACEUTICALS INC Annual Income Tax Expense (Benefit) in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2021.
  • Rigel Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
  • Rigel Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was -$60K.
  • Rigel Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $605K.
  • Rigel Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2018 was $0.000.
  • Rigel Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2017 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.